Urologie
Gestion et optimisation de l’hémostase
Antifibrinolytiques
Intraoperative use of tranexamic acid to reduce transfusion rate in patients undergoing radical retropubic prostatectomy: double blind, randomised, placebo controlled trial. (manokatra rohy)
Loharanon-kevitra: BMJ 2011;343:d5701.
Rakitra: PubMed 22012809
https://www.ncbi.nlm.nih.gov/pubmed/22012809 (manokatra rohy)
Tranexamic acid in patients undergoing noncardiac surgery. (manokatra rohy)
Loharanon-kevitra: N Engl J Med. 2022;386(21):1986-97.
Rakitra: PubMed 35363452
DOI: 10.1056/NEJMoa2201171
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. (manokatra rohy)
Loharanon-kevitra: Cochrane Database Syst Rev 2011;(3):CD001886.
Rakitra: PubMed 21412876
DOI: 10.1002/14651858.CD001886.pub4
https://www.ncbi.nlm.nih.gov/pubmed/21412876 (manokatra rohy)
Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. (manokatra rohy)
Loharanon-kevitra: BMJ 2012;344:e3054.
Rakitra: PubMed 22611164
https://www.ncbi.nlm.nih.gov/pubmed/22611164 (manokatra rohy)
Tranexamic acid reduces blood loss during percutaneous nephrolithotomy: a prospective randomized controlled study. (manokatra rohy)
Loharanon-kevitra: J Urol 2013;189(5):1757-61.
Rakitra: PubMed 23123376
DOI: 10.1016/j.juro.2012.10.115
https://www.ncbi.nlm.nih.gov/pubmed/23123376 (manokatra rohy)
Facteur VII activé recombinant (rFVIIa)
Recombinant activated factor VIIa for the treatment of bleeding in major abdominal surgery including vascular and urological surgery: a review and meta-analysis of published data. (manokatra rohy)
Loharanon-kevitra: Crit Care 2008;12(1):R14.
Rakitra: PubMed 18279513
DOI: 10.1186/cc6788
https://www.ncbi.nlm.nih.gov/pubmed/18279513 (manokatra rohy)